Editor's Correspondence |

NSAIDs and Hypertension

Paul S. Aisen, MD; Kimberly Schafer, MS; Michael Grundman, MD; Ronald Thomas, PhD; Leon J. Thal, MD
Arch Intern Med. 2003;163(9):1115. doi:10.1001/archinte.163.9.1115-a.
Text Size: A A A
Published online


Curhan et al1 report an increased risk of hypertension with use of NSAIDs in younger women based on an analysis of data collected from participants in the Nurses' Health Study II. Our experience in a recently completed double-blind randomized controlled trial of NSAID therapy for Alzheimer disease (unpublished data, 2003) provides evidence of risk of hypertension in older individuals.

In the trial, 351 individuals (mean age, 74 years; 53% women) with probable Alzheimer disease were randomly assigned to receive rofecoxib, 25 mg by mouth daily; naproxen sodium, 220 mg by mouth twice daily; or placebo for 1 year. Enrollment criteria required that subjects be medically stable. A history of hypertension was recorded for 115 subjects (33%); these subjects were balanced across the treatment groups. Mean ± SD systolic blood pressure at study entry was 134 ± 16 mm Hg and mean ± SD diastolic blood pressure was 75 ± 10 mm Hg, with no difference across treatment groups. Study visits were conducted at 1, 3, 6, 9, and 12 months after enrollment, with interval history, physical examination, and laboratory studies obtained at each visit. Any significant change in symptoms, physical examination findings, or laboratory values noted during or between study visits was captured as an adverse event.

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
First page PDF preview





Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment


Some tools below are only available to our subscribers or users with an online account.

Web of Science® Times Cited: 6

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Topics
PubMed Articles

Users' Guides to the Medical Literature
Clinical Scenario

Users' Guides to the Medical Literature
Example 1: Diabetes and Target Blood Pressure